|
Warner Bros Discovery Inc (WBD) |
|
|
|
| |
Warner Bros Discovery Inc Income Statement Quarterly
WBD
|
Select the Financial Report: |
Period: |
Fiscal Year: |
|
|
|
|
INCOME STATEMENT
(Quarterly GAAP In millions $) |
(Sep 30 2024)
III. Quarter |
(Jun 30 2024)
II. Quarter |
(Mar 31 2024)
I. Quarter |
(Dec 31 2023)
IV. Quarter |
(Sep 30 2023)
III. Quarter |
| Revenue From Contract With Customer Excluding Assessed Tax |
9,623.00 |
9,713.00 |
9,958.00 |
|
9,979.00 |
| Revenue From Contract With Customer Excluding Assessed Tax |
- |
- |
- |
|
- |
| Distribution Revenue |
- |
- |
- |
|
- |
| Total Revenue |
9,623.00 |
9,713.00 |
9,958.00 |
10,284.00 |
9,979.00 |
| Cost Of Goods And Service Excluding DepreciationDepletion AndAmortization |
5,181.00 |
6,204.00 |
6,058.00 |
5,896.00 |
5,309.00 |
| Gross
Profit |
4,442.00 |
3,509.00 |
3,900.00 |
4,388.00 |
4,670.00 |
| Selling, Administration, Marketing |
2,385.00 |
2,461.00 |
2,232.00 |
2,455.00 |
2,291.00 |
| Depriciation & Amortization |
1,762.00 |
1,744.00 |
1,888.00 |
2,024.00 |
1,989.00 |
| Research & development |
- |
- |
- |
- |
- |
| Restructuring Charges |
9.00 |
117.00 |
35.00 |
14.00 |
293.00 |
| Other operatinig exp. /-income |
494.00 |
9,395.00 |
12.00 |
77.00 |
- |
| Unusual Expense /-Income |
- |
- |
- |
- |
- |
| Impairment Charges And Disposal Group Not Discontinued Operation Gain Loss On Disposal |
5.00 |
- |
- |
- |
- |
| Interest Expense Nonoperating |
-494.00 |
- |
- |
- |
- |
| Total operating costs including COS |
9,342.00 |
19,921.00 |
10,225.00 |
10,466.00 |
9,882.00 |
| Operating income/-loss
|
281.00 |
-10,208.00 |
-267.00 |
-182.00 |
97.00 |
|
Other Deductions / - Income |
| Interest expense |
- |
- |
515.00 |
502.00 |
574.00 |
| Interest income |
- |
- |
- |
- |
- |
| Net interest expense/-income |
- |
- |
515.00 |
502.00 |
574.00 |
| Extinguishment of Debt |
23.00 |
-542.00 |
- |
-27.00 |
22.00 |
| Loss (Income) from Equity Method Investments |
- |
- |
- |
- |
- |
| Foreign Currency Transaction (Gain) Loss |
- |
- |
- |
- |
- |
| Allowances, Health Care Trust Fund And Other |
- |
- |
- |
- |
- |
| Unexpected (Gain) Loss |
- |
- |
- |
- |
- |
| Other loss/ -income |
436.00 |
369.00 |
37.00 |
-44.00 |
33.00 |
| Total costs & expenses |
9,801.00 |
19,748.00 |
10,777.00 |
10,897.00 |
10,511.00 |
| Income /-loss before income taxes |
-178.00 |
-10,035.00 |
-819.00 |
-613.00 |
-532.00 |
| Income taxes expenses/-benefit |
-319.00 |
-7.00 |
136.00 |
-221.00 |
-125.00 |
| Income after income taxes |
141.00 |
-10,028.00 |
-955.00 |
-392.00 |
-407.00 |
| Net income/-loss
of other equity |
- |
- |
- |
- |
- |
| Income/-loss
from cont. Ops. |
141.00 |
-10,028.00 |
-955.00 |
-392.00 |
-407.00 |
| Accounting change |
- |
- |
- |
- |
- |
| Discontinued operations |
- |
- |
- |
- |
- |
| Extraordinary items |
- |
- |
- |
- |
- |
| Net Income/-loss |
141.00 |
-10,028.00 |
-955.00 |
-392.00 |
-407.00 |
| Noncontrolling interests |
-3.00 |
52.00 |
-4.00 |
-2.00 |
-2.00 |
| Prefered dividends |
- |
- |
- |
- |
- |
| Other |
- |
- |
- |
- |
- |
| Income/-loss to shareholder |
135.00 |
-9,986.00 |
-966.00 |
-400.00 |
-417.00 |
| EBIT |
-178.00 |
-10,035.00 |
-304.00 |
-111.00 |
42.00 |
| EBITD |
1,584.00 |
-8,291.00 |
1,584.00 |
1,913.00 |
2,031.00 |
| EBITDA |
1,584.00 |
-8,291.00 |
1,584.00 |
1,913.00 |
2,031.00 |
| Per
Share (GAAP Quarterly, in $) |
(Sep 30 2024)
III. Quarter |
(Jun 30 2024)
II. Quarter |
(Mar 31 2024)
I. Quarter |
(Dec 31 2023)
IV. Quarter |
(Sep 30 2023)
III. Quarter |
| Basic EPS (excl. extra
items) |
0.06 |
-4.07 |
-0.40 |
-0.16 |
-0.17 |
| Extraordinary items |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Basic Net EPS |
0.06 |
-4.07 |
-0.40 |
-0.16 |
-0.17 |
| Basic shares outstanding (Mill.
of Units) |
2,453.00 |
2,451.00 |
2,443.00 |
2,437.00 |
2,438.00 |
| EPS other shares |
- |
- |
- |
- |
- |
| Diluted Net EPS |
0.05 |
-4.07 |
-0.40 |
-0.16 |
-0.17 |
| Diluted average shares (Mill.
of Units) |
2,470.00 |
2,451.00 |
2,443.00 |
2,442.19 |
2,438.00 |
| Dividend per share |
- |
- |
- |
- |
- |
|
|
